1. Home
  2. AWRE vs XLO Comparison

AWRE vs XLO Comparison

Compare AWRE & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWRE
  • XLO
  • Stock Information
  • Founded
  • AWRE 1986
  • XLO 2016
  • Country
  • AWRE United States
  • XLO United States
  • Employees
  • AWRE N/A
  • XLO N/A
  • Industry
  • AWRE Computer Software: Prepackaged Software
  • XLO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AWRE Technology
  • XLO Health Care
  • Exchange
  • AWRE Nasdaq
  • XLO Nasdaq
  • Market Cap
  • AWRE 47.3M
  • XLO 40.9M
  • IPO Year
  • AWRE 1996
  • XLO 2021
  • Fundamental
  • Price
  • AWRE $2.21
  • XLO $0.80
  • Analyst Decision
  • AWRE
  • XLO Buy
  • Analyst Count
  • AWRE 0
  • XLO 2
  • Target Price
  • AWRE N/A
  • XLO $3.00
  • AVG Volume (30 Days)
  • AWRE 27.8K
  • XLO 604.4K
  • Earning Date
  • AWRE 10-29-2025
  • XLO 11-07-2025
  • Dividend Yield
  • AWRE N/A
  • XLO N/A
  • EPS Growth
  • AWRE N/A
  • XLO N/A
  • EPS
  • AWRE N/A
  • XLO N/A
  • Revenue
  • AWRE $17,428,000.00
  • XLO $15,001,000.00
  • Revenue This Year
  • AWRE N/A
  • XLO $519.70
  • Revenue Next Year
  • AWRE N/A
  • XLO $44.57
  • P/E Ratio
  • AWRE N/A
  • XLO N/A
  • Revenue Growth
  • AWRE 2.72
  • XLO 536.45
  • 52 Week Low
  • AWRE $1.35
  • XLO $0.62
  • 52 Week High
  • AWRE $2.95
  • XLO $1.70
  • Technical
  • Relative Strength Index (RSI)
  • AWRE 37.97
  • XLO 52.39
  • Support Level
  • AWRE $2.22
  • XLO $0.73
  • Resistance Level
  • AWRE $2.56
  • XLO $0.90
  • Average True Range (ATR)
  • AWRE 0.13
  • XLO 0.06
  • MACD
  • AWRE -0.01
  • XLO 0.00
  • Stochastic Oscillator
  • AWRE 0.00
  • XLO 41.23

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

Share on Social Networks: